• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌蛋白 LMP1 诱导的自分泌 CCL3 和 CCL4 促进 Epstein-Barr 病毒引发的 B 细胞增殖。

Autocrine CCL3 and CCL4 induced by the oncoprotein LMP1 promote Epstein-Barr virus-triggered B cell proliferation.

机构信息

Graduate Institute of Microbiology, College of Medicine, National Taiwan University, Taipei, Taiwan.

出版信息

J Virol. 2013 Aug;87(16):9041-52. doi: 10.1128/JVI.00541-13. Epub 2013 Jun 12.

DOI:10.1128/JVI.00541-13
PMID:23760235
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3754032/
Abstract

Epstein-Barr virus (EBV) alters the regulation and expression of a variety of cytokines in its host cells to modulate host immune surveillance and facilitate viral persistence. Using cytokine antibody arrays, we found that, in addition to the cytokines reported previously, two chemotactic cytokines, CCL3 and CCL4, were induced in EBV-infected B cells and were expressed at high levels in all EBV-immortalized lymphoblastoid cell lines (LCLs). Furthermore, EBV latent membrane protein 1 (LMP1)-mediated Jun N-terminal protein kinase activation was responsible for upregulation of CCL3 and CCL4. Inhibition of CCL3 and CCL4 in LCLs using a short hairpin RNA approach or by neutralizing antibodies suppressed cell proliferation and caused apoptosis, indicating that autocrine CCL3 and CCL4 are required for LCL survival and growth. Importantly, significant amounts of CCL3 were detected in EBV-positive plasma from immunocompromised patients, suggesting that EBV modulates this chemokine in vivo. This study reveals the regulatory mechanism and a novel function of CCL3 and CCL4 in EBV-infected B cells. CCL3 might be useful as a therapeutic target in EBV-associated lymphoproliferative diseases and malignancies.

摘要

EB 病毒(EBV)改变了宿主细胞中多种细胞因子的调节和表达,以调节宿主免疫监视并促进病毒持续存在。通过细胞因子抗体阵列,我们发现,除了之前报道的细胞因子外,两种趋化细胞因子 CCL3 和 CCL4 在 EBV 感染的 B 细胞中被诱导,并在所有 EBV 永生化淋巴母细胞系(LCL)中高水平表达。此外,EBV 潜伏膜蛋白 1(LMP1)介导的 Jun N 末端蛋白激酶激活负责上调 CCL3 和 CCL4。使用短发夹 RNA 方法或中和抗体抑制 LCL 中的 CCL3 和 CCL4,可抑制细胞增殖并引起细胞凋亡,表明自分泌 CCL3 和 CCL4 是 LCL 存活和生长所必需的。重要的是,在免疫功能低下患者的 EBV 阳性血浆中检测到大量的 CCL3,提示 EBV 在体内调节这种趋化因子。本研究揭示了 CCL3 和 CCL4 在 EBV 感染的 B 细胞中的调节机制和新功能。CCL3 可能是 EBV 相关淋巴增生性疾病和恶性肿瘤的治疗靶点。

相似文献

1
Autocrine CCL3 and CCL4 induced by the oncoprotein LMP1 promote Epstein-Barr virus-triggered B cell proliferation.癌蛋白 LMP1 诱导的自分泌 CCL3 和 CCL4 促进 Epstein-Barr 病毒引发的 B 细胞增殖。
J Virol. 2013 Aug;87(16):9041-52. doi: 10.1128/JVI.00541-13. Epub 2013 Jun 12.
2
Maintenance of Epstein-Barr Virus Latent Status by a Novel Mechanism, Latent Membrane Protein 1-Induced Interleukin-32, via the Protein Kinase Cδ Pathway.通过一种新机制维持爱泼斯坦-巴尔病毒潜伏状态,即潜伏膜蛋白1通过蛋白激酶Cδ途径诱导白细胞介素-32。
J Virol. 2015 Jun;89(11):5968-80. doi: 10.1128/JVI.00168-15. Epub 2015 Mar 25.
3
The c-Jun N-terminal kinase pathway is critical for cell transformation by the latent membrane protein 1 of Epstein-Barr virus.c-Jun氨基末端激酶途径对于爱泼斯坦-巴尔病毒潜伏膜蛋白1介导的细胞转化至关重要。
Virology. 2008 Feb 20;371(2):246-56. doi: 10.1016/j.virol.2007.09.044. Epub 2007 Oct 29.
4
Dysregulation of Dual-Specificity Phosphatases by Epstein-Barr Virus LMP1 and Its Impact on Lymphoblastoid Cell Line Survival.双特异性磷酸酶的失调由 Epstein-Barr 病毒 LMP1 引起及其对淋巴母细胞系存活的影响。
J Virol. 2020 Jan 31;94(4). doi: 10.1128/JVI.01837-19.
5
TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation.TRAF1协调多聚泛素信号传导以增强爱泼斯坦-巴尔病毒LMP1介导的生长和存活途径激活。
PLoS Pathog. 2015 May 21;11(5):e1004890. doi: 10.1371/journal.ppat.1004890. eCollection 2015 May.
6
Epstein-Barr virus EBNA2 directs doxorubicin resistance of B cell lymphoma through CCL3 and CCL4-mediated activation of NF-κB and Btk.爱泼斯坦-巴尔病毒EBNA2通过CCL3和CCL4介导的NF-κB和Btk激活导致B细胞淋巴瘤的阿霉素耐药。
Oncotarget. 2017 Jan 17;8(3):5361-5370. doi: 10.18632/oncotarget.14243.
7
c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection.c-Myc在原发性B细胞感染后早期抑制爱泼斯坦-巴尔病毒潜伏膜蛋白1的转录。
J Virol. 2018 Jan 2;92(2). doi: 10.1128/JVI.01178-17. Print 2018 Jan 15.
8
Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus.爱泼斯坦-巴尔病毒潜伏膜蛋白1对人B细胞中Th2趋化因子CCL17和CCL22的选择性诱导
J Virol. 2004 Feb;78(4):1665-74. doi: 10.1128/jvi.78.4.1665-1674.2004.
9
Requirement for LMP1-induced RON receptor tyrosine kinase in Epstein-Barr virus-mediated B-cell proliferation.LMP1 诱导的 RON 受体酪氨酸激酶在 Epstein-Barr 病毒介导的 B 细胞增殖中的作用。
Blood. 2011 Aug 4;118(5):1340-9. doi: 10.1182/blood-2011-02-335448. Epub 2011 Jun 9.
10
Analysis of Epstein-Barr virus-regulated host gene expression changes through primary B-cell outgrowth reveals delayed kinetics of latent membrane protein 1-mediated NF-κB activation.通过原代 B 细胞扩增分析 Epstein-Barr 病毒调节的宿主基因表达变化,揭示潜伏膜蛋白 1 介导的 NF-κB 激活的时滞动力学。
J Virol. 2012 Oct;86(20):11096-106. doi: 10.1128/JVI.01069-12. Epub 2012 Aug 1.

引用本文的文献

1
Epstein-Barr virus induces aberrant B cell migration and diapedesis via FAK-dependent chemotaxis pathways.爱泼斯坦-巴尔病毒通过黏着斑激酶依赖的趋化途径诱导异常B细胞迁移和渗出。
Nat Commun. 2025 May 19;16(1):4581. doi: 10.1038/s41467-025-59813-z.
2
Multi-modal analysis reveals tumor and immune features distinguishing EBV-positive and EBV-negative post-transplant lymphoproliferative disorders.多模态分析揭示了区分EB病毒阳性和EB病毒阴性移植后淋巴增殖性疾病的肿瘤和免疫特征。
Cell Rep Med. 2024 Dec 17;5(12):101851. doi: 10.1016/j.xcrm.2024.101851. Epub 2024 Dec 9.
3
Comprehensive characterization of tumor immune landscape following oncolytic virotherapy by single-cell RNA sequencing.单细胞 RNA 测序分析溶瘤病毒治疗后肿瘤免疫图谱的全面特征。
Cancer Immunol Immunother. 2022 Jun;71(6):1479-1495. doi: 10.1007/s00262-021-03084-2. Epub 2021 Oct 30.
4
Mucosal-associated invariant T (MAIT) cells provide B-cell help in vaccinated and subsequently SIV-infected Rhesus Macaques.黏膜相关不变 T(MAIT)细胞在接种疫苗并随后感染 SIV 的恒河猴中为 B 细胞提供辅助。
Sci Rep. 2020 Jun 22;10(1):10060. doi: 10.1038/s41598-020-66964-0.
5
Astrocyte-to-astrocyte contact and a positive feedback loop of growth factor signaling regulate astrocyte maturation.星形胶质细胞之间的接触和生长因子信号的正反馈环调节星形胶质细胞的成熟。
Glia. 2019 Aug;67(8):1571-1597. doi: 10.1002/glia.23630. Epub 2019 Apr 29.
6
Molecular mechanisms of EBV-driven cell cycle progression and oncogenesis.EBV 驱动的细胞周期进展和致癌的分子机制。
Med Microbiol Immunol. 2019 Oct;208(5):573-583. doi: 10.1007/s00430-018-0570-1. Epub 2018 Nov 1.
7
Frequency of EBV LMP-1 Promoter and Coding Variations in Burkitt Lymphoma Samples in Africa and South America and Peripheral Blood in Uganda.非洲和南美洲伯基特淋巴瘤样本以及乌干达外周血中EBV LMP-1启动子和编码变异的频率
Cancers (Basel). 2018 Jun 2;10(6):177. doi: 10.3390/cancers10060177.
8
EBV and Apoptosis: The Viral Master Regulator of Cell Fate?EBV 和细胞凋亡:病毒对细胞命运的主调控因子?
Viruses. 2017 Nov 13;9(11):339. doi: 10.3390/v9110339.
9
Epstein-Barr virus EBNA2 directs doxorubicin resistance of B cell lymphoma through CCL3 and CCL4-mediated activation of NF-κB and Btk.爱泼斯坦-巴尔病毒EBNA2通过CCL3和CCL4介导的NF-κB和Btk激活导致B细胞淋巴瘤的阿霉素耐药。
Oncotarget. 2017 Jan 17;8(3):5361-5370. doi: 10.18632/oncotarget.14243.
10
Recent insights in the pathogenesis of post-transplantation lymphoproliferative disorders.移植后淋巴细胞增生性疾病发病机制的最新见解
World J Transplant. 2016 Sep 24;6(3):505-16. doi: 10.5500/wjt.v6.i3.505.

本文引用的文献

1
Immune surveillance and therapy of lymphomas driven by Epstein-Barr virus protein LMP1 in a mouse model.在小鼠模型中,由 Epstein-Barr 病毒蛋白 LMP1 驱动的淋巴瘤的免疫监视和治疗。
Cell. 2012 Feb 17;148(4):739-51. doi: 10.1016/j.cell.2011.12.031.
2
Epstein-Barr virus oncoprotein LMP1 mediates survivin upregulation by p53 contributing to G1/S cell cycle progression in nasopharyngeal carcinoma.EB 病毒致癌蛋白 LMP1 通过 p53 介导 survivin 的上调,促进鼻咽癌细胞 G1/S 细胞周期进程。
Int J Mol Med. 2012 Apr;29(4):574-80. doi: 10.3892/ijmm.2012.889. Epub 2012 Jan 17.
3
The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC).EBV 编码的潜伏膜蛋白 LMP1 和 LMP2 在鼻咽癌(NPC)发病机制中的作用。
Semin Cancer Biol. 2012 Apr;22(2):144-53. doi: 10.1016/j.semcancer.2012.01.004. Epub 2012 Jan 12.
4
Requirement for LMP1-induced RON receptor tyrosine kinase in Epstein-Barr virus-mediated B-cell proliferation.LMP1 诱导的 RON 受体酪氨酸激酶在 Epstein-Barr 病毒介导的 B 细胞增殖中的作用。
Blood. 2011 Aug 4;118(5):1340-9. doi: 10.1182/blood-2011-02-335448. Epub 2011 Jun 9.
5
Cytokine signatures of transformed B cells with distinct Epstein-Barr virus latencies as a potential diagnostic tool for B cell lymphoma.具有不同 Epstein-Barr 病毒潜伏期的转化 B 细胞的细胞因子特征可作为 B 细胞淋巴瘤的潜在诊断工具。
Cancer Sci. 2011 Jun;102(6):1236-41. doi: 10.1111/j.1349-7006.2011.01924.x. Epub 2011 Apr 1.
6
Epstein-Barr Virus latent membrane protein 1 induces Snail and epithelial-mesenchymal transition in metastatic nasopharyngeal carcinoma.EB 病毒潜伏膜蛋白 1 诱导转移性鼻咽癌中的 Snail 和上皮-间充质转化。
Br J Cancer. 2011 Mar 29;104(7):1160-7. doi: 10.1038/bjc.2011.38. Epub 2011 Mar 8.
7
A pivotal role for CXCL12 signaling in HPV-mediated transformation of keratinocytes: clues to understanding HPV-pathogenesis in WHIM syndrome.CXCL12 信号在 HPV 介导的角质形成细胞转化中的关键作用:理解 WHIM 综合征中 HPV 发病机制的线索。
Cell Host Microbe. 2010 Dec 16;8(6):523-33. doi: 10.1016/j.chom.2010.11.006.
8
Endogenous latent membrane protein 1 in Epstein-Barr virus-infected nasopharyngeal carcinoma cells attracts T lymphocytes through upregulation of multiple chemokines. Epstein-Barr 病毒感染鼻咽癌细胞中的内源性潜伏膜蛋白 1 通过上调多种趋化因子吸引 T 淋巴细胞。
Virology. 2010 Sep 30;405(2):464-73. doi: 10.1016/j.virol.2010.06.037. Epub 2010 Jul 15.
9
The Epstein-Barr virus-encoded G protein-coupled receptor BILF1 hetero-oligomerizes with human CXCR4, scavenges Gαi proteins, and constitutively impairs CXCR4 functioning.EB 病毒编码的 G 蛋白偶联受体 BILF1 与人类 CXCR4 形成异源寡聚体,消耗 Gαi 蛋白,并持续损害 CXCR4 的功能。
J Biol Chem. 2010 Sep 17;285(38):29632-41. doi: 10.1074/jbc.M110.115618. Epub 2010 Jul 9.
10
Human tumor-associated viruses and new insights into the molecular mechanisms of cancer.人类肿瘤相关病毒与癌症分子机制的新见解。
Oncogene. 2008 Dec;27 Suppl 2:S31-42. doi: 10.1038/onc.2009.351.